386961008: Aprotinin (substance)

SNOMED CT Concept\Substance\...

\Substance categorized by disposition\Substance with effector mechanism of action (substance)\Enzyme inhibitor\Enzyme inhibitor protein\Protease inhibitor protein (substance)\Aprotinin (substance)

\A grouper concept for substances that are used in medicinal products for medical treatment, and also psychoactive substances that have few or no legitimate medical uses or that are not legally available to the person using them.\Hematologic agent (substance)\Hemostatic agent (substance)\Plasmin inhibitor agent (substance)\Aprotinin (substance)
\A grouper concept for substances that are used in medicinal products for medical treatment, and also psychoactive substances that have few or no legitimate medical uses or that are not legally available to the person using them.\Enzyme inhibitor protein\Protease inhibitor protein (substance)\Aprotinin (substance)

\Substance categorised by structure\Chemical\Chemical categorized by structure (substance)\...

\Nitrogen and/or nitrogen compound (substance)\Nitrogen compound\Organic nitrogen compound\Amide and/or amide derivative (substance)\Substituted amide (substance)\Polypeptide\Protein\Enzyme inhibitor protein\Protease inhibitor protein (substance)\Aprotinin (substance)

\Organic compound\Organic nitrogen compound\Amide and/or amide derivative (substance)\Substituted amide (substance)\Polypeptide\Protein\Enzyme inhibitor protein\Protease inhibitor protein (substance)\Aprotinin (substance)

\Biological substance\Protein and/or protein derivative\Protein\Enzyme inhibitor protein\Protease inhibitor protein (substance)\Aprotinin (substance)
\Biological substance\Polypeptide\Protein\Enzyme inhibitor protein\Protease inhibitor protein (substance)\Aprotinin (substance)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2003. Module: SNOMED CT core

Descriptions:

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Aprotinin (substance)	Is a	Hemostatic agent (substance)	false	Inferred relationship	Some
Aprotinin (substance)	Is a	classe d'allergènes	false	Inferred relationship	Some
Aprotinin (substance)	Is a	allergène médicamenteux	false	Inferred relationship	Some
Aprotinin (substance)	Is a	Plasmin inhibitor	false	Inferred relationship	Some
Aprotinin (substance)	Is a	Protease inhibitor protein (substance)	true	Inferred relationship	Some
Aprotinin (substance)	Is a	Plasmin inhibitor agent (substance)	true	Inferred relationship	Some
Aprotinin (substance)	This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context.	Protease inhibitor protein (disposition)	true	Inferred relationship	Some

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Product containing aprotinin (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Aprotinin (substance)	Inferred relationship	Some	1
Aprotinin adverse reaction (disorder)	Causative agent (attribute)	True	Aprotinin (substance)	Inferred relationship	Some	1
Allergy to aprotinin (finding)	Causative agent (attribute)	False	Aprotinin (substance)	Inferred relationship	Some
Aprotinin [pancreatitis] [see chapter b]	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Aprotinin (substance)	Inferred relationship	Some
Trasylol injection 5mL	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Aprotinin (substance)	Inferred relationship	Some
Trasylol injection 10mL	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Aprotinin (substance)	Inferred relationship	Some
Aprotinin injection 5mL	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Aprotinin (substance)	Inferred relationship	Some
Aprotinin injection 10mL	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Aprotinin (substance)	Inferred relationship	Some
Aprotinin [fibrinolytic]	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Aprotinin (substance)	Inferred relationship	Some
aprotinine 10 000 U.I./mL, fiole de 50 mL de solution pour injection	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Aprotinin (substance)	Inferred relationship	Some
Aprotinin injection	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Aprotinin (substance)	Inferred relationship	Some
Trasylol injection	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Aprotinin (substance)	Inferred relationship	Some
Aprotinin 10,000kiu/mL injection solution 200mL vial	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Aprotinin (substance)	Inferred relationship	Some
Aprotinin 10,000kiu/mL injection solution 100mL vial	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Aprotinin (substance)	Inferred relationship	Some
Allergy to aprotinin (finding)	Causative agent (attribute)	True	Aprotinin (substance)	Inferred relationship	Some	1
Product containing only aprotinin (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Aprotinin (substance)	Inferred relationship	Some	1
Aprotinin-containing product in parenteral dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Aprotinin (substance)	Inferred relationship	Some	1
Product containing only aprotinin in parenteral dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Aprotinin (substance)	Inferred relationship	Some	1
Aprotinin 1.4 mg/mL solution for injection	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Aprotinin (substance)	Inferred relationship	Some	1
Aprotinin 1.4 mg/mL solution for injection	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Aprotinin (substance)	Inferred relationship	Some	1
Aprotinin therapy	Direct substance	True	Aprotinin (substance)	Inferred relationship	Some	1

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
1461139017	Aprotinin (substance)	en	Fully specified name	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
1481075013	Aprotinin	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
51231000195117	aprotinina	it	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module
792051000172111	aprotinine	fr	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module
65451000195116	Aprotinin	de	Synonym (core metadata concept)	Active	Entire term case sensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module